The results revealed that sitagliptin could attenuate obesity-induced hepatic insulin resistance and steatosis, suppress inflammation by regulating macrophage M1/M2 polarization imbalance, and promote liver autophagy via AMPK/mTOR signaling pathway. This evidence concerns the gene MTOR and obesity due to melanocortin 4 receptor deficiency.